UBS Group AG Grows Stock Holdings in Maximus, Inc. $MMS

UBS Group AG grew its holdings in Maximus, Inc. (NYSE:MMS) by 76.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 610,354 shares of the health services provider’s stock after purchasing an additional 265,095 shares during the quarter. UBS Group AG owned about 1.12% of Maximus worth $52,686,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of MMS. JPMorgan Chase & Co. boosted its holdings in Maximus by 19.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 200,331 shares of the health services provider’s stock valued at $18,304,000 after purchasing an additional 33,136 shares during the last quarter. Divisadero Street Capital Management LP boosted its holdings in Maximus by 93.5% in the 3rd quarter. Divisadero Street Capital Management LP now owns 183,872 shares of the health services provider’s stock valued at $16,800,000 after purchasing an additional 88,872 shares during the last quarter. Stephens Investment Management Group LLC raised its holdings in Maximus by 49.0% in the 3rd quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider’s stock valued at $65,873,000 after buying an additional 237,097 shares during the period. Dimensional Fund Advisors LP raised its holdings in Maximus by 2.0% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider’s stock valued at $170,812,000 after buying an additional 36,989 shares during the period. Finally, WINTON GROUP Ltd purchased a new stake in Maximus in the 3rd quarter valued at about $6,208,000. 97.21% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CEO Bruce Caswell acquired 3,175 shares of the business’s stock in a transaction dated Tuesday, February 10th. The shares were acquired at an average price of $78.45 per share, with a total value of $249,078.75. Following the completion of the transaction, the chief executive officer owned 328,013 shares of the company’s stock, valued at $25,732,619.85. The trade was a 0.98% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO David Mutryn acquired 1,000 shares of the business’s stock in a transaction dated Monday, February 9th. The shares were bought at an average cost of $75.62 per share, for a total transaction of $75,620.00. Following the transaction, the chief financial officer directly owned 40,037 shares of the company’s stock, valued at approximately $3,027,597.94. This trade represents a 2.56% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 1.80% of the company’s stock.

Maximus Stock Up 1.2%

Shares of NYSE:MMS opened at $65.29 on Wednesday. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.34 and a quick ratio of 2.34. The firm has a market capitalization of $3.56 billion, a PE ratio of 9.94 and a beta of 0.60. The firm’s 50-day moving average is $69.11 and its two-hundred day moving average is $80.28. Maximus, Inc. has a 1 year low of $60.75 and a 1 year high of $100.00.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.84 by $0.01. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.37 billion. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The business’s revenue for the quarter was down 4.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.61 earnings per share. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. Analysts predict that Maximus, Inc. will post 8.46 EPS for the current year.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be paid a dividend of $0.33 per share. The ex-dividend date is Friday, May 15th. This represents a $1.32 dividend on an annualized basis and a yield of 2.0%. Maximus’s dividend payout ratio is 20.09%.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. Weiss Ratings lowered shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a report on Tuesday, February 24th. Zacks Research lowered shares of Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Finally, Wall Street Zen lowered shares of Maximus from a “buy” rating to a “hold” rating in a report on Monday, February 23rd. Two analysts have rated the stock with a Hold rating, According to MarketBeat, Maximus currently has an average rating of “Hold”.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.